Forty-nine percent of mental health patients exhibit medication non-adherence, with associated risk for mental health instability. Medication non-adherence can contribute to poor treatment outcomes, aggravation of diseases, and increased occurrences of adverse medical events that costs the United States billions of dollars annually. The overarching aim of this quality improvement project (QIP) was to increase medication adherence to support mental health stability among patients ages 18–65 years at an outpatient mental health clinic in the Midwestern United States. The project incorporated the Medication Adherence Rating Scale (MARS) instrument and shared decision-making (SDM) intervention to assess for increased medication adherence after SDM. This QIP illustrated the positive impact of SDM on MARS scores and empowerment of patients to participate actively in treatment decisions through shared responsibility between patients, providers, and health-care systems.
AokiY.YajuY.UtsumiT.SanyaoluL.StormM.TakaesuY.WatanabeK.WatanabeN.DuncanE.EdwardsA. G. (2022). Shared decision-making interventions for people with mental health conditions. The Cochrane Database of Systematic Reviews, 11(11), CD007297. https://doi.org/10.1002/14651858.CD007297.pub3
3.
ChukwujekwuO.AdesokunO. (2017). Prevalence of medication non-adherence among psychiatric patients in a tertiary hospital in Nigeria. Journal of Biosciences and Medicines, 5(4), 1–10. https://doi.org/10.4236/jbm.2017.54001
4.
De las CuevasC.PeñateW. (2014). To what extent psychiatric patients feel involved in decision making about their mental health care? Relationships with socio-demographic, clinical, and psychological variables. Acta Neuropsychiatrica, 26(6), 372–381. https://doi.org/10.1017/neu.2014.21
FentonW. S.BlylerC. R.HeinssenR. K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23(4), 637–651. https://doi.org/10.1093/schbul/23.4.637
7.
FondG.BoyerL.BoucekineM.AdenL. A.SchürhoffF.TessierA.AndrianarisoaM.BernaF.BrunelL.CapdevielleD.ChereauI.MalletJ.DenizotH.DoreyJ. M.DubertretC.DubreucqJ.FagetC.GabayetF., ReyR., … FACE-SZ (Fonda Mental Academic Centers of Expertise for Schizophrenia) group. (2017). Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset. Schizophrenia Research, 182 (1), 84–89. https://doi.org/10.1016/j.schres.2016.10.023
GebeyehuD. A.MulatH.BekanaL.AsemamawN. T.BirarraM. K.TakeleW. W.AngawD. A. (2019). Psychotropic medication non-adherence among patients with severe mental disorder attending at Bahir Dar Felege Hiwote Referral Hospital, Northwest Ethiopia. BioMed Central Research Notes, 12(1), 102. https://doi.org/10.1186/s13104-019-4126-2
KassisI. T.GhuloumS.MousaH.BenerA. (2016). Treatment non-compliance of psychiatric patients and associated factors: Are patients satisfied with their psychiatrist?British Journal of Medicine and Medical Research, 4(2), 785. https://doi.org/10.9734/BJMMR/2014/6127
MaanC.HussainN.LeninR. (2015). Factors affecting non-compliance among psychiatric patients in the Regional Institute of Medical Sciences. Imphal International Journal of Humanities and Social Science Journal of Pharmacy and Biological Science, 5, 01–07. http://www.iosrphr.org/papers/v5i1/A0510107.pdf
16.
MeepringS.TulyakulP.SathagathonthunG.SupasriJ. (2021). A review of factors relating to medication non-adherence in patients with schizophrenia. Global Journal of Health Science, 13(10), 1–52. https://doi.org/10.5539/gjhs.v13n10p52
17.
MenearM.GirardA.DugasM.GervaisM.GilbertM.GagnonM. P. (2022). Personalized care planning and shared decision making in collaborative care programs for depression and anxiety disorders: A systematic review. PloS One, 17(6), e0268649. https://doi.org/10.1371/journal.pone.0268649
Rummel-KlugeC.SchusterT.PetersS.KisslingW. (2008). Partial compliance with antipsychotic medication is common in patients with schizophrenia. Australian & New Zealand Journal of Psychiatry, 42(5), 382–388. https://doi.org/10.1080/00048670801961107
21.
SemahegnA.TorpeyK.ManuA.AssefaN.TesfayeG.AnkomahA. (2020). Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Systematic Reviews, 7(1), 10. https://doi.org/10.1186/s13643-018-0676-y
22.
ShayL. A.LafataJ. E. (2015). Where is the evidence? A systematic review of shared decision making and patient outcomes. Medical Decision Making, 35(1), 114–131. https://doi.org/10.1177/0272989X14551638
23.
TanakaM. (2022). Orem’s nursing self-care deficit theory: A theoretical analysis focusing on its philosophical and sociological foundation. Nursing Forum, 57(3), 480–485. https://doi.org/10.1111/nuf.12696
24.
ThompsonK.KulkarniJ.SergejewA. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for psychoses. Schizophrenia Research, 42(1), 241–247. https://doi.org/10.1016/s0920-9964(99)00130-9
VelliganD. I.WeidenP. J.SajatovicM.ScottJ.CarpenterD.RossR.DochertyJ. P., & Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. The Journal of Clinical Psychiatry, 70( Suppl 4), 1–48.
